Time to first decision: 2.4 Weeks
Submission to publication: 4 Weeks
Acceptance rate: 26%
Cancer Insight (CI) is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. Cancer Insight aims to disseminate and communicate scientific advancement and impactful discoveries on the field of oncology to researchers, academics, clinicians, and the public worldwide. Anser Press retains ownership of Cancer Insight.
Types of articles:
The following fields are covered: